✦ LIBER ✦
P093 INFLIXIMAB REINTRODUCTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE PREVIOUSLY TREATED WITH A 3-INFUSION INDUCTION REGIMEN IS NOT ASSOCIATED TO A HIGHER RATE OF IMMUNE-MEDIATED ADVERSE EFFECTS
✍ Scribed by Y. Zabana; E. Domènech; E. Cabré; M. Mañosa; R. García-Castellanos; S. Carrión; T. Ortiz; M. Gassull
- Book ID
- 119637290
- Publisher
- Oxford University Press
- Year
- 2008
- Weight
- 73 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1873-9954
No coin nor oath required. For personal study only.